Dopamine neurons express multiple isoforms of the nuclear receptor nurr1 with diminished transcriptional activity

Journal of Neurochemistry

Volumn 95, Issue 5, 2005, Pages 1342-1350

  Michelhaugh, Sharon K ^a   Vaitkevicius, Henrikas ^a   Wang, Jun ^a   Bouhamdan, Mohamad ^a   Krieg, Alexys R ^a   Walker, Jennifer L ^a   Mendiratta, Varsha ^a   Bannon, Michael J ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Dopamine transporter; Nerve growth factor inducible binding response element; NR4A2; SK N AS; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

CELL NUCLEUS RECEPTOR; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN NURR1A; PROTEIN NURR1B; PROTEIN NURR1C; TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; DOPAMINERGIC NERVE CELL; EXON; FRAMESHIFT MUTATION; GENE DELETION; HUMAN; HUMAN TISSUE; LIGAND BINDING; MALE; MESENCEPHALON; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; TRANSCRIPTION REGULATION;

ANIMALS; BLOTTING, NORTHERN; BRAIN; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOPAMINE; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; NEUROBLASTOMA; NEURONS; PROTEIN ISOFORMS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSFECTION;

ANIMALIA;

EID: 28844453709     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03458.x     Document Type: Article

References (43)

1. Backman C., Perlmann T., Wallen A., Hoffer B. J. and Morales M. (1999) A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res. 851, 125-132.
2. Bannon M. J. and Whitty C. J. (1997) Age-related and regional differences in dopamine transporter mRNA expression in human mid-brain. Neurology 48, 969-977.
3. Bannon M. J., Pruetz B., Manning-Bog A. B., Whitty C. J., Michelhaugh S. K., Sacchetti P., Granneman J. G., Mash D. C. and Schmidt C. J. (2002) Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proc. Natl Acad. Sci. USA 99, 6382-6385.
4. Bannon M. J., Pruetz B., Barfield E. and Schmidt C. J. (2004) Transcription factors specifying dopamine phenotype are decreased in cocaine users. Neuroreport 15, 401-404.
5. Bommer M., Benecke A., Gronemeyer H. and Rochette-Egly C. (2002) TIF2 mediates the synergy between RARalpha 1 activation functions AF-1 and AF-2. J. Biol. Chem. 277, 37 961-37 966.
6. Carvey P. M., Ling Z. D., Sortwell C. E., Pitzer M. R., McGuire S. O., Storch A. and Collier T. J. (2001) A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp. Neurol. 171, 98-108.
7. Castillo S. O., Xiao Q., Lyu M. S., Kozak C. A. and Nikodem V. M. (1997) Organization, sequence, chromosomal localization, and promoter identification of the mouse orphan nuclear receptor Nurr1 gene. Genomics 41, 250-257.
8. Castillo S. O., Baffi J. S., Palkovits M., Goldstein D. S., Kopin I. J., Witta J., Magnuson M. A. and Nikodem V. M. (1998a) Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol. Cell Neurosci. 11, 36-46.
9. Castillo S. O., Xiao Q., Kostrouch Z., Dozin B. and Nikodem V. M. (1998b) A divergent role of COOH-terminal domains in Nurr1 and Nur77 transactivation. Gene Expr. 7, 1-12.
10. Castro D. S., Arvidsson M., Bondesson B. M. and Perlmann T. (1999) Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2. J. Biol. Chem. 274, 37 483-37 490.
11. Chawla A., Repa J. J., Evans R. M. and Mangelsdorf D. J. (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294, 1866-1870.
12. Chu Y., Kompoliti K., Cochran E. J., Mufson E. J. and Kordower J. H. (2002) Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J. Comp. Neurol. 450, 203-214.
13. Galleguillos D., Vecchiola A., Fuentealba J. A., Ojeda V., Alvarez K., Gomez A. and Andres M. E. (2004) PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1. J. Biol. Chem. 279, 2005-2011.
14. Ichinose H., Ohye T., Suzuki T., Sumi-Ichinose C., Nomura T., Hagino Y. and Nagatsu T. (1999) Molecular cloning of the human Nurr1 gene: characterization of the human gene and cDNAs. Gene 230, 233-239.
15. Kim J. Y., Koh H. C., Lee J. Y. et al. (2003a) Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J. Neurochem. 85, 1443-1454.
16. Kim K. S., Kim C. H., Hwang D. Y., Seo H., Chung S., Hong S. J., Lim J. K., Anderson T. and Isacson O. (2003b) Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J. Neurochem. 85, 622-634.
17. Law S. W., Conneely O. M., DeMayo F. J. and O'Malley B. W. (1992) Identification of a new brain-specific transcription factor, NURR1. Mol. Endocrinol. 6, 2129-2135.
18. Maira M., Martens C., Batsche E., Gauthier Y. and Drouin J. (2003) Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol. Cell Biol. 23, 763-776.
19. Maruyama K., Tsukada T., Ohkura N., Bandoh S., Hosono T. and Yamaguchi K. (1998) The NGFI-B subfamily of the nuclear receptor superfamily (review). Int. J. Oncol. 12, 1237-1243.
20. McGrath P. C. and Neifeld J. P. (1985) Inhibition of human neuroblastoma by dopamine antagonists. Surgery 98, 135-142.
21. Metivier R., Penot G., Flouriot G. and Pakdel F. (2001) Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Mol. Endocrinol. 15, 1953-1970.
22. Nordzell M., Aarnisalo P., Benoit G., Castro D. S. and Perlmann T. (2004) Defining an N-terminal activation domain of the orphan nuclear receptor Nurr1. Biochem. Biophys. Res. Commun. 313, 205-211.
23. Ohkura N., Hosono T., Maruyama K., Tsukada T. and Yamaguchi K. (1999) An isoform of Nurr1 functions as a negative inhibitor of the NGFI-B family signaling. Biochim. Biophys. Acta 1444, 69-79.
24. Okabe T., Takayanagi R., Imasaki K., Haji M., Nawata H. and Watanabe T. (1995) cDNA cloning of a NGFI-B/nur77-related transcription factor from an apoptotic human T cell line. J. Immunol. 154, 3871-3879.
25. Ordentlich P., Yan Y., Zhou S. and Heyman R. A. (2003) Identification of the antineoplastic agent 6-mercaptopurine as an activator of the orphan nuclear hormone receptor Nurr1. J. Biol. Chem. 278, 24 791-24 799.
26. Puntervoll P., Linding R., Gemund C. et al. (2003) ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins. Nucl. Acids Res. 31, 3625-3630.
27. Sacchetti P., Brownschidle L. A., Granneman J. G. and Bannon M. J. (1999) Characterization of the 5′-flanking region of the human dopamine transporter gene. Brain Res. Mol. Brain Res. 74, 167-174.
28. Sacchetti P., Mitchell T. R., Granneman J. G. and Bannon M. J. (2001) Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J. Neurochem. 76, 1565-1572.
29. Sacchetti P., Dwornik H., Formstecher P., Rachez C. and Lefebvre P. (2002) Requirements for heterodimerization between the orphan nuclear receptor Nurr1 and retinoid X receptors. J. Biol. Chem. 277, 35 088-35 096.
30. Sakurada K., Ohshima-Sakurada M., Palmer T. D. and Gage F. H. (1999) Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126, 4017-4026.
31. Saucedo-Cardenas O., and Conneely O. M. (1996) Comparative distribution of NURR1 and NUR77 nuclear receptors in the mouse central nervous system. J. Mol. Neurosci. 7, 51-63.
32. Saucedo-Cardenas O., Quintana-Hau J. D., Le W. D., Smidt M. P., Cox J. J., De M. F., Burbach J. P. and Conneely O. M. (1998) Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl Acad. Sci. USA 95, 4013-4018.
33. Song Z., Krishna S., Thanos D., Strominger J. L. and Ono S. J. (1994) A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor. J. Exp. Med. 180, 1763-1774.
34. Torii T., Kawarai T., Nakamura S. and Kawakami H. (1999) Organization of the human orphan nuclear receptor Nurr1 gene. Gene 230, 225-232.
35. Verity A. N., Wyatt T. L., Lee W., Hajos B., Baecker P. A., Eglen R. M. and Johnson R. M. (1999) Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. J. Neurosci. Res. 55, 187-197.
36. Wang J. and Bannon M. J. (2005) Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J. Neurochem. 93, 474-482.
37. Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., Xu H., Walker N. P. and Perlmann T. (2003) Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423, 555-560.
38. Wansa K. D., Harris J. M. and Muscat G. E. (2002) The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment. J. Biol. Chem. 277, 33001-33011.
39. Wansa K. D., Harris J. M., Yan G., Ordentlich P. and Muscat G. E. (2003) The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine. J. Biol. Chem. 278, 24 776-24 790.
40. Warnmark A., Treuter E., Wright A. P. and Gustafsson J. A. (2003) Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol. Endocrinol. 17, 1901-1909.
41. Xiao Q., Castillo S. O. and Nikodem V. M. (1996) Distribution of messenger RNAs for the orphan nuclear receptors Nurr1 and Nur77 (NGFI-B) in adult rat brain using in situ hybridization. Neuroscience 75, 221-230.
42. Zetterstrom R. H., Williams R., Perlmann T. and Olson L. (1996) Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res. Mol. Brain Res. 41, 111-120.
43. Zetterstrom R. H., Solomin L., Jansson L., Hoffer B. J., Olson L. and Perlmann T. (1997) Dopamine neuron agenesis in Nurr1-deficient mice. Science 276, 248-250.